Top Smart Score Stocks
Analysts' Top Stocks
Insiders' Hot Stocks
Daily Stock Ratings
Daily Insider Transactions
Electronic Vehicles Stocks
Coronavirus Vaccine Stocks
High Dividend Stocks
My Portfolio Analysis
Profile & Performance
My Public Profile
Find & Follow Experts
Top 25 Wall Street Analysts
Top 25 Financial Bloggers
Top 25 Corporate Insiders
Top 25 Hedge Fund Managers
Top Individual Investors
Ideas & Insights
Calendars & Events
Stock Market Holidays
Become an Affiliate
Plans & Pricing
BeiGene’s Tislelizumab Gets Approval for First-Line Treatment of Advanced Non-Squamous NSCLC in China
China-based biopharmaceutical firm BeiGene (BGNE) has received approval for its anti-PD-1 antibody tislelizumab from the China National Medical...
Jun 23, 2021
Novartis and Molecular Partners Begin EMPATHY Clinical Trial
Novartis Ag (NVS) announced that together with Molecular Partners it has begun clinical trial EMPATHY. The EMPATHY trial...
May 27, 2021
Novartis’ Cholesterol Drug Fails To Get FDA Approval; Shares Drop 3%
Shares of Novartis were down more than 3% in Monday’s pre-market trading after the Swiss drugmaker said that...
Dec 21, 2020
Novartis Snaps Up Cadent For Up To $770M; Street Sees 19% Upside
Novartis has clinched a deal to buy neuroscience company Cadent Therapeutics for up to $770 million, to expand...
Dec 17, 2020
Novartis Kicks Off $2.5B Share Buyback Program; Street Sees 22% Upside
Novartis announced on Tuesday that it will initiate a share buyback plan of up to $2.5 billion, which...
Nov 24, 2020
Novartis Snaps Up Vedero Bio In $280M Deal; Street Says Buy
Swiss drugmaker Novartis announced the acquisition of ocular gene therapy company Vedere Bio for a total consideration of...
Oct 29, 2020
Novartis Reveals Positive Five-Year Results For Migraine Drug Aimovig
Novartis (NVS) has announced results from the five-year, open-label treatment period of a Phase 2 study in episodic...
Oct 05, 2020
BioNTech Buys German Site From Novartis To Boost Covid-19 Vaccine Supply
BioNTech has signed an agreement to buy a new manufacturing site in Germany from Novartis AG in a...
Sep 17, 2020
Novartis’ Skin Cancer Drug Candidate Fails Late-Stage Trial Target
Novartis AG announced on Saturday that its investigational spartalizumab immunotherapy drug combined with Tafinlar and Mekinist therapies failed...
Aug 23, 2020
Novartis Unveils €150M Antibiotics Investment For Europe
Novartis (NVS) generics and biosimilars division, Sandoz, has announced a joint investment with the Austrian federal government to...
Jul 27, 2020
Novartis To Sell Covid-19 Drugs At Zero-Profit To Low-Income Countries
Novartis AG (NVS) announced Thursday that its Sandoz division will sell 15 generic drugs to treat COVID-19 symptoms...
Jul 16, 2020
Novartis Strikes $678M Settlement Agreement With U.S. Authorities
Novartis AG (NVS) has agreed to pay $678 million to settle a civil U.S. lawsuit which claimed that...
Jul 02, 2020
Novartis Scores FDA Ilaris Approval For Rare Type Of Arthritis
The U.S. Food and Drug Administration has approved Novartis’ (NVS) Ilaris (canakinumab) injection for the treatment of Active...
Jun 17, 2020